Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.

HL Mando has patented a composition for intravenous injection containing beta-cyclodextrin molecules with hydroxypropyl groups, suitable for treating Niemann-Pick disease Type C. The composition is ...